PreveCeutical Medical Inc. (CSE: PREV) (OTCID: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical") is pleased to announce that the Australian Patent Office has granted Australian Patent No.

Glycine is a major inhibitory neurotransmitter that reduces nerve activity, helping to regulate pain signals, motor control and sensory processing. Glycine transporter 2 (GlyT2) is a key regulator of ...

Your skin can reveal secrets about your liver's health. Subtle changes like yellowing, persistent itching without a rash, or unusual palm redness may ...

Innovative sweat sampling techniques could revolutionize diagnostics, offering insights into glucose levels and environmental ...

Americans have developed a unique “disdain for pain,” leading to the excessive use of opioids and other unproductive treatments, neurosurgeon Sanjay Gupta said Saturday at The Texas Tribune Festival’s ...

Listening to a favorite song can trigger a profound emotional response that rivals the feelings produced by biological necessities. A new brain imaging study reveals that music activates the same ...

RespireRx Pharmaceuticals Inc. (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal ...

RespireRx Pharmaceuticals Inc. (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal ...

On November 13, 2025, effective November 14, 2025 the Securities and Exchange Commission (“Commission”), in Administrative Proceeding File No. 3-22541, in Release No. 104178 issued an Order Making ...

Living with chronic pain can feel overwhelming, especially when conventional treatments fall short. You've probably heard ...

But transgender rights has become an exception, a place where the culture war burns hot as public opinion shifts rightward — ...